Magnetic Resonance Imaging Contrast Media
- Magnetic Resonance Imaging Contrast Media
- Accession Number
- ATC Classification
Drug Drug Description Gadodiamide A gadolinium-based contrast agent used for the visualization of lesions with vascularity during magnetic resonance imaging (MRI) scans. Gadoversetamide A gadolinium compound used as a contrast agent in MRI tests of the brain, spine, and liver. Gadoteridol A medication used to improve the contrast of MRI scans for better visualization. Gadobenic acid A gadolinium compound used as a contrast agent in MRIs. Perflubron Investigated for use/treatment in cardiac surgery, hemorrhage, and ileus. Gadobutrol A contrast agent used during diagnostic procedures to visualize disrupted areas of blood brain barrier (BBB) and/or abnormal vascularity of the central nervous system. Gadofosveset trisodium An intravenous contrast agent used during magnetic resonance angiography (MRA) to evaluate aortoiliac occlusive disease (AIOD) in adults with peripheral vascular disease. Mangafodipir An organ-specific paramagnetic contrast agent indicated for the imaging of the hepatobiliary system and detecting lesions in the liver and pancreas. Gadoxetic acid A gadolinium-based contrast agent used in magnetic resonance imaging (MRI) to help characterize lesions in the liver. Gadoteric acid A diagnostic contrast agent used with magnetic resonance imaging to provide contrast enhancement for intracranial and spinal lesions with abnormal blood brain barrier or abnormal vascularity, and for whole body imaging. Ferric ammonium citrate Not Annotated Ferumoxsil Not Annotated Ferric oxide An ingredient used in a number of skin protecting products. Gadopentetic acid A gadolinium compound used as a contrast agent in MRIs.
- Drugs & Drug Targets